News
RVTY
151.59
-0.55%
-0.84
Diamond Hill Mid Cap Strategy Q3 2026 Portfolio Review
Seeking Alpha · 1d ago
Solid Earnings Reflect Revvity's (NYSE:RVTY) Strength As A Business
Simply Wall St · 2d ago
Revvity Is Maintained at Neutral by JP Morgan
Dow Jones · 3d ago
Revvity Price Target Raised to $165.00/Share From $160.00 by JP Morgan
Dow Jones · 3d ago
JP Morgan Maintains Neutral on Revvity, Raises Price Target to $165
Benzinga · 3d ago
Analysts Offer Insights on Healthcare Companies: Kardigan, Inc. (KARD), Moderna (MRNA) and Revvity (RVTY)
TipRanks · 3d ago
Revvity price target raised to $165 from $160 at JPMorgan
TipRanks · 3d ago
RBC Capital Sticks to Its Hold Rating for Revvity (RVTY)
TipRanks · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Revvity (RVTY)
TipRanks · 3d ago
Weekly Report: what happened at RVTY last week (1109-1113)?
Weekly Report · 3d ago
Analysts Offer Insights on Healthcare Companies: Alpha Tau (DRTS), Revvity (RVTY) and Biogen (BIIB)
TipRanks · 3d ago
KeyBanc Keeps Their Buy Rating on Revvity (RVTY)
TipRanks · 3d ago
Revvity Announces Investor Day Focused on Scientific Intelligence
TipRanks · 6d ago
Revvity to Showcase Strategy for Powering Scientific Intelligence at 2026 Investor Day
Barchart · 6d ago
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Revvity (RVTY) and Ovid Therapeutics (OVID)
TipRanks · 11/12 11:01
ELV or RVTY: Which Is the Better Value Stock Right Now?
NASDAQ · 11/11 15:40
Learn Why The Bull Case For Revvity (RVTY) Could Change Following Earnings Beat
Simply Wall St · 11/11 01:39
Revvity Consensus Price Target Raised 18.01% to $174.65
NASDAQ · 11/10 05:07
Weekly Report: what happened at RVTY last week (1102-1106)?
Weekly Report · 11/09 09:43
Revvity (RVTY) Climbed, But What Is Behind The Fresh Attention?
Simply Wall St · 11/08 14:25
More
Webull provides a variety of real-time RVTY stock news. You can receive the latest news about Revvity Inc through multiple platforms. This information may help you make smarter investment decisions.
About RVTY
Revvity, Inc. provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. It has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards life sciences customers. The segment offers instruments, reagents, software, subscriptions, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the areas of reproductive health and emerging market diagnostics. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.